NEW YORK (Reuters Health) – Patients hospitalized with community-acquired pneumonia are no better off when treated with prednisolone, according to trial results from The Netherlands. In fact, there’s…
NEW YORK (Reuters Health) – Oral anticoagulation might no longer be necessary after successful atrial fibrillation ablation, not even in patients at moderate-high risk for thromboembolism, a recent…
NEW YORK (Reuters Health) – Contrary to expectations, individual genetic markers don’t add up to a genetic risk score that’s any better than traditional risk factors for predicting…
NEW YORK (Reuters Health) – In treating acute coronary syndromes, a slow response to clopidogrel in the first hour of administration predicts a low response at 24 hours…
NEW YORK (Reuters Health) – In chronic obstructive pulmonary disease (COPD), vertebral deformities often contribute to excess height loss with aging – which in turn may lead to…
NEW YORK (Reuters Health) – The risk of hip fracture is significantly lower when organic nitrates are used as needed rather than continuously, according to a February 3rd…
NEW YORK (Reuters Health) – In patients with chest pain of uncertain origin, emergency department evaluation combining clinical history and N-terminal pro-B-type natriuretic peptide (NT-proBNP) level, without exercise…
NEW YORK (Reuters Health) – Three weeks of hypofractionated whole-breast radiotherapy is at least as good as 5 weeks of standard radiotherapy after breast-conserving surgery for invasive cancer,…
NEW YORK (Reuters Health) – Use of paroxetine during tamoxifen therapy reduces the breast cancer survival benefit by 25% or more depending on the amount of time the…
NEW YORK (Reuters Health) – With intensive medical therapy, fewer than 5% of patients with asymptomatic carotid stenosis will gain additional benefit from revascularization, according to a report…